Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oklahoma for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oklahoma only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oklahoma (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Justin Parschauer (NPI 1073845921)

Field	Value
Entity Type	Individual
Organization	Justin Parschauer
Address	2424 E 21st St Ste 200
City	Tulsa
State	OK
ZIP	74114
Taxonomy	Ophthalmology Physician
NPI Enumerated	February 3, 2010

Payer Source	Total Paid
Medicare	$3.2M
Medicaid	$0

Key Findings

This provider’s billing profile is effectively single‑payer: lifetime Medicare revenue is $3.2M while Medicaid revenue is none, indicating no Medicaid billing on file. The practice’s financial footprint is therefore concentrated entirely in the Medicare population rather than split across payers.

Revenue concentration is extreme: the precomputed top three Medicare codes (J2777, J0178, Q5128) account for 85.1% of this provider’s total Medicare revenue. Those three codes break down to $1.4M for J2777 (42.9%), $1.1M for J0178 (33.7%), and $274.3K for Q5128 (8.5%), showing the practice depends heavily on a small set of high‑value injectable therapies.

Service mix and business implications point to a retina/interventional ophthalmology focus: high revenue from J2777, J0178, and Q5128 indicates primary activity is intravitreal anti‑VEGF and related biologic injections, supported by frequent isolated intravitreal injection procedure billing under 67028. That code mix suggests a throughput model centered on recurring injection visits and associated retina imaging rather than predominantly office‑based medical management.

Competitive standing for key drugs is mixed: J2777 is a clear above‑typical performer, ranking #109 of 2039 providers (95th percentile), which positions the provider as a high‑volume national user of faricimab. J0178 and Q5128 are more typical to modestly above typical in national volume—J0178 ranks #775 of 3204 (76th percentile) and Q5128 ranks #114 of 373 (70th percentile)—so the provider is a major national participant for faricimab and a solid, but less dominant, participant for other anti‑VEGF agents.

Imaging and procedure volumes are also unusually high for several codes: 92134 appears as an extreme outlier (3.2K claims, $87.4K revenue; 99th percentile) and 67028 is notably above typical (2.3K claims, $196.4K revenue; 94th percentile). These elevated imaging and injection procedure volumes corroborate a high‑throughput procedural retina practice with substantial diagnostic imaging supporting ongoing intravitreal therapy.

Clinical visit/E&M billing is relatively small compared with procedural revenue: 99214 accounts for $27.7K (342 claims) and 92014 $74.3K (929 claims), which together are minor compared with the multi‑hundred‑thousand and million‑dollar lines from biologic injections. This pattern indicates revenue primarily driven by procedure and drug administration rather than by prolonged evaluation and management visits.

Tenure is long enough to establish a stable referral and treatment pattern: NPI enumeration date is 2010-02-03 (~16 years ago), consistent with an established practice and long‑standing presence in the Medicare billing landscape. That tenure supports the interpretation that current code mix and volumes reflect durable service lines rather than a transient shift.

The absence of Medicaid billing represents both a constraint and a strategic signal: with Medicaid reported as none, the provider currently operates without Medicaid revenue exposure, which limits payer diversity and Medicaid patient access through this clinician. For payer contracting and network planning, this profile should be treated as a Medicare‑focused retina/injection practice rather than a mixed‑payer community provider.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

16 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	49,320	$30	$1.4M
J0178	Injection, aflibercept, 1 mg	1,560	$690	$1.1M
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	1,270	$220	$274.3K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,260	$90	$196.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,240	$30	$87.4K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	930	$80	$74.3K
J9035	Injection, bevacizumab, 10 mg	910	$50	$47.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	340	$80	$27.7K
92004	The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits.	170	$90	$15.7K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	140	$100	$13.6K

Showing 1–10 of 16

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oklahoma Distribution

Justin Parschauer — 3 of 16 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oklahoma

Full comparison — all codes billed, vs. state median

16 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	7	30	790	$690	$801.2K
J2777	4	20	23,040	$30	$781.1K
Q5128	1	10	800	$220	$182.2K
67028	6	40	720	$80	$88.9K
J9035	5	30	330	$50	$23.5K
92235	4	20	60	$100	$19.5K
99214	1,328	5,560	130	$70	$18.4K
92014	22	550	130	$70	$16.6K
67228	11	10	30	$240	$10.4K
92012	159	220	60	$50	$6.4K

Showing 1–10 of 16

Related Providers

Other providers that share a Tax Identification Number (TIN) with Justin Parschauer, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Thomas Finley	OK	Ophthalmology Physician	$4.8M	$0
Tulsa Retina Consultants PLLC	OK	Ophthalmology Physician	$0	$2.2M
Alan Hromas	KS	Retina Specialist (Ophthalmology) Physician	$2.1M	$0
Kyle Piwonka	CO	Retina Specialist (Ophthalmology) Physician	$1.7M	$0
Joaquin Tosi	VA	Retina Specialist (Ophthalmology) Physician	$105K	$22.4K

Nearby Providers

Other providers in the same ZIP code as Justin Parschauer, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Family & Children's Services, Inc	OK	Community/Behavioral Health Agency	$0	$77.4M
Jerry L Greer Dds PC	OK	Oral and Maxillofacial Surgery (Dentist)	$0	$2.5M
Family & Children's Services, Inc	OK	Psychiatry Physician	$0	$1.7M
Scott Meyers	OK	MOHS-Micrographic Surgery Physician	$691.4K	$0
Lindsay Cunningham	OK	Rheumatology Physician	$502.1K	$0
Mark Lehman	OK	Dermatology Physician	$350.7K	$0
George Monks	OK	Dermatology Physician	$327.7K	$0
Kelli Lovelace	OK	Dermatology Physician	$267.3K	$0
Jacqueline Guidry	OK	Dermatology Physician	$266.1K	$0
Kristen Rice	OK	Dermatology Physician	$256.7K	$0

Justin Parschauer — Billing Profile & Reimbursement Data

Sign up for Justin Parschauer — Billing Profile & Reimbursement Data policy alerts

Justin Parschauer — Billing Profile & Reimbursement Data

Sign up for Justin Parschauer — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References